輔助生殖技術市場規模、佔有率、成長分析（按技術、按程序、最終用戶、按地區）- 產業預測，2024-2031 年

Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Technique(In Vitro Fertilization, Artificial Insemination, Frozen Embryo Transfer, Others), By Procedure, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月23日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球輔助生殖技術市場價值將從2023年的266.7億美元增加至2022年的253億美元，預測期內（2024-2031年）複合年成長率為5.40%，到2031年預計將達到70百萬。

由於幾個關鍵因素，全球輔助生殖技術（ART）市場正在見證顯著成長。不孕率的上升、醫療技術的進步以及對 ART 治療的認知和接受度的提高是這一擴張的主要原因。由於生活方式的改變、延遲懷孕、環境影響和各種醫療狀況，越來越多的人尋求不孕不育治療，從而增加了對體外受精（IVF）、顯微授精（ICSI）和配子捐贈等ART手術的需求。採用延時成像系統和改進成分和穩定性的胚胎培養基等創新技術，顯著提高了 ART 治療的成功率。這些進步將有助於更好地監測和最佳化胚胎髮育，從而改善治療結果。此外，對 ART 的日益接受也推動了市場的成長。從歷史上看，圍繞不孕症和輔助生殖技術的社會恥辱一直是其接受的障礙。然而，由於社會態度、教育努力和支持團體的變化，ART 現在被認為是面臨不孕症挑戰的夫婦的合法且有效的選擇。這種日益成長的接受度導致更多的人接受不孕症治療，增加了對 ART 服務的需求並進一步擴大了市場。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 義大利
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Vitrolife AB（Sweden）
CooperSurgical, Inc.（US）
Cook Medical, Inc.（US）
Irvine Scientific（US）
Genea Limited（Australia）
Ferring Pharmaceuticals（Switzerland）
Merck KGaA（Germany）
Thermo Fisher Scientific, Inc.（US）
Esco Group（Singapore）
Hamilton Thorne, Inc.（Canada）
Nidacon International AB（Sweden）
Kitazato Corporation（Japan）
OvaScience（US）
The Cooper Companies, Inc.（US）
IGENOMIX（Spain）
IVFtech ApS（Denmark）
Origio a/s（Denmark）
Cryolab Ltd.（United Kingdom）
Anecova（Switzerland）
Progyny, Inc.（US）

簡介目錄

Product Code: SQMIG35G2228

Global assisted reproductive market was valued at USD 25.30 billion in 2022 and is expected to rise from USD 26.67 billion in 2023 to reach a value of USD 40.67 billion by 2031, at a CAGR of 5.40% during the forecast period (2024-2031).

The global assisted reproductive technology (ART) market is experiencing notable growth, driven by several key factors. Rising infertility rates, advances in medical technology, and increasing awareness and acceptance of ART procedures are major contributors to this expansion. Changing lifestyles, delayed pregnancies, environmental influences, and various medical conditions are leading more individuals to seek fertility treatments, thereby boosting the demand for ART procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete donation. The introduction of innovative technologies, such as time-lapse imaging systems and improved embryo culture media with enhanced composition and stability, has significantly increased the success rates of ART procedures. These advancements help in better monitoring and optimizing embryo development, which in turn improves outcomes. Additionally, the growing acceptance of ART is fueling market growth. Historically, social stigma surrounding infertility and ART procedures created barriers to their use. However, shifting societal attitudes, along with educational initiatives and support groups, have helped normalize ART as a legitimate and effective option for couples facing infertility challenges. This increased acceptance has led to more individuals pursuing fertility treatments, thereby driving the demand for ART services and further expanding the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Assisted Reproductive market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Assisted Reproductive Market Segmental Analysis

The assisted reproductive technology (ART) market is segmented by type, application, and region. Based on type, the market can be segmented into in vitro fertilization (IVF) (fresh donor, frozen donor, fresh non-donor, frozen non-donor), artificial insemination (intrauterine insemination, intracervical insemination, intravaginal insemination, intratubal insemination) and surrogacy. Based on end use, the market is segmented into fertility clinics, hospitals, specialized ART centers, and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Assisted Reproductive Market

The global assisted reproductive technology (ART) market is expanding significantly due to rising infertility rates worldwide. Factors such as changing lifestyles, delayed pregnancies, and environmental influences contribute to the increasing demand for ART. These technologies provide solutions for individuals and couples facing fertility challenges, helping them achieve their goal of conceiving.

Restraints in the Global Assisted Reproductive Market

Ethical and legal concerns present significant challenges for the ART market, especially in certain regions. The application of ART procedures raises various ethical issues and is subject to diverse regulations. Key concerns include the appropriate disposal of embryos, the extent of donor anonymity, and the regulation of emerging techniques such as gamete and embryo editing. These issues can affect the availability and acceptance of specific ART procedures and, consequently, influence market dynamics.

Market Trends of the Global Assisted Reproductive Market

A notable trend in the global Assisted Reproductive Technology (ART) market is the rising demand for advanced genetic testing and screening technologies. As reproductive medicine progresses, there is an increasing focus on ensuring the health and viability of embryos before implantation. Techniques like preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) are becoming more prominent as they help identify genetic abnormalities and chromosomal disorders in embryos. This trend is fueled by couples' desire for healthy children and growing awareness of how genetic testing can enhance the success rates of ART procedures.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Case Study Analysis
Ecosystem of the Market
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Assisted Reproductive Technology (ART) Market by Type

Market Overview
In vitro fertilization (IVF)
- Fresh Donor
- Frozen Donor
- Fresh non-Donor
- Frozen non-Donor
Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intravaginal Insemination
- Intratubal Insemination
Surrogacy

Assisted Reproductive Technology (ART) Market by End Use

Market Overview
Fertility clinics
Hospitals
Specialized ART centers
Research institutes

Assisted Reproductive Technology (ART) Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Group (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Thorne, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidacon International AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kitazato Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OvaScience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Cooper Companies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IGENOMIX (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IVFtech ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origio a/s (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolab Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anecova (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progyny, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments